companydata.dkTAKEDA PHARMA A/S
CVR: 16406899
Secondary names: NYCOMED DANMARK A/S, DAK LABORATORIES A/S, NYCOMED DAK A/S
The financial health of TAKEDA PHARMA A/S appears to be fluctuating, with a notable decline in profitability over the past few years. Revenue peaked at 1,939,231,000 DKK in 2021 but has since decreased to 1,102,419,000 DKK in 2025, while profit has significantly dropped from 667,744,000 DKK in 2021 to just 12,162,000 DKK in 2025. Despite a positive equity trend, increasing from 81,238,000 DKK in 2022 to 368,294,000 DKK in 2025, the company's profit margins are concerning. Positioned within the pharmaceutical wholesale industry, its recent performance raises questions about operational efficiency and market competitiveness.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er udvikling og fremstilling af samt handel med lægemidler og hermed beslægtede varer.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 1.1 mia. | 12.2 mio. | 581.3 mio. | 368.3 mio. | 68 | |
History
Ownership
Management
Directors
Board
Production units (8)
Similar companies
Companies in the same industry and area